Speaker illustration

Doctor Mario Centore

University Hospital San Giovanni di Dio e Ruggi dAragona, Salerno (Italy)

Member of:

European Society of Cardiology

Intravenous antiplatelet therapy with cangrelor vs. tirofiban in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention

Event: ESC Congress 2022

Topic: Antiplatelet Drugs

Session: Short and long-term antiplatelet therapy in clinical practice


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb